BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SPN-821 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SPN-821\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07226661-864@assetmemo.bio
DTSTAMP:20261121T005642Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:SPN-821: Phase 2 readout est. (NCT07226661)
DESCRIPTION:SPN-821\, phase 2\, Major Depressive Disorder.\nStudy: Double-b
 lind\, Placebo-controlled Study in Adults With Major Depressive Disorder\n
 Estimated primary completion: 31 December 2026. This is a ClinicalTrials.g
 ov estimate\, not a confirmed readout date\, and it can move.\nDrug page: 
 https://assetmemo.bio/drug/spn-821#upcoming-events\nRegistry record: https
 ://clinicaltrials.gov/study/NCT07226661
URL:https://assetmemo.bio/drug/spn-821#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
